Cohance Life

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE03QK01018
  • NSEID: COHANCE
  • BSEID: 543064
INR
462.00
2.85 (0.62%)
BSENSE

Nov 20

BSE+NSE Vol: 4.36 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003386,
    "name": "Cohance Life",
    "stock_name": "Cohance Life",
    "full_name": "Cohance Lifesciences Ltd",
    "name_url": "stocks-analysis/cohance-life",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "462.00",
    "chg": 2.85,
    "chgp": "0.62%",
    "dir": 1,
    "prev_price": "459.15",
    "mcapval": "17,557.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543064,
    "symbol": "COHANCE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE03QK01018",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "4.36 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/cohance-life-1003386-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Cohance Lifesciences Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-sell-4271158",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/CohanceLifescie_mojoScore_4271158.png",
        "date": "2026-11-22 10:10:06",
        "description": "Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 November 2026, providing investors with the most recent and relevant data to assess the company’s outlook."
      },
      {
        "title": "Cohance Lifesciences Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-sell-4245491",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/CohanceLifescie_mojoScore_4245491.png",
        "date": "2026-10-31 10:10:03",
        "description": "Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Cohance Lifesciences Ltd Hits Intraday Low Amid Price Pressure on 30 Oct 2026",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/cohance-lifesciences-ltd-hits-intraday-low-amid-price-pressure-on-30-oct-2026-4244988",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/CohanceLifescie_priceRelatedfactors_4244988.png",
        "date": "2026-10-30 13:22:54",
        "description": "Shares of Cohance Lifesciences Ltd declined sharply today, touching an intraday low of Rs 445, reflecting a 7.55% drop as the stock underperformed its sector and the broader market amid persistent selling pressure and subdued market sentiment."
      },
      {
        "title": "Cohance Lifesciences Gains 5.30%: 4 Key Technical and Fundamental Factors Driving the Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/cohance-lifesciences-gains-530-4-key-technical-and-fundamental-factors-driving-the-week-4228554",
        "imagepath": "",
        "date": "2026-10-17 12:01:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>12 Oct:</strong> Stock opens at Rs.444.60, gains 0.91% amid Sensex decline</p>\n                    <p><strong>13 Oct:</strong> Downgrade to Strong Sell by MarketsMOJO announced; stock falls 1.66%</p>\n                    <p><strong>14 Oct:</strong> Technical momentum shifts to mildly bearish; stock rebounds 2.02%</p>\n                    <p><strong>15 Oct:</strong> Mixed technical signals as stock gains 2.91% on heavy volume</p>\n                    <p><strong>16 Oct:</strong> Weekly close at Rs.463.95 with 1.07% gain; weekly technical trend turns mildly bullish</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n           ..."
      },
      {
        "title": "Cohance Lifesciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/cohance-lifesciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-4227241",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/CohanceLifescie_technicaldot_4227241.png",
        "date": "2026-10-16 08:05:05",
        "description": "Cohance Lifesciences Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance on the weekly charts. Despite this positive development, the company’s overall technical indicators present a complex picture, with mixed signals across key metrics such as MACD, RSI, Bollinger Bands, and moving averages. This analysis delves into the recent technical parameter changes, contextualising them within the broader market and sector performance."
      },
      {
        "title": "Cohance Lifesciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/cohance-lifesciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-4226048",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/CohanceLifescie_technicaldot_4226048.png",
        "date": "2026-10-15 08:04:44",
        "description": "Cohance Lifesciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. Despite a modest day gain of 2.02%, the stock remains under pressure with a strong sell rating and a challenging long-term performance compared to the broader market."
      },
      {
        "title": "Cohance Lifesciences Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/cohance-lifesciences-ltd-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-4225091",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/CohanceLifescie_mojoScore_4225091.png",
        "date": "2026-10-14 08:49:06",
        "description": "Cohance Lifesciences Ltd has been downgraded from a Sell to a Strong Sell rating as of 13 Oct 2026, reflecting deteriorating fundamentals and a shift towards bearish technical indicators. The company’s weak financial performance, expensive valuation, and negative technical trends have collectively triggered this downgrade, signalling caution for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Cohance Lifesciences Ltd Faces Technical Momentum Shift Amid Bearish Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/cohance-lifesciences-ltd-faces-technical-momentum-shift-amid-bearish-signals-4224903",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/CohanceLifescie_technicaldot_4224903.png",
        "date": "2026-10-14 08:06:31",
        "description": "Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, signalling a transition from sideways movement to a mildly bearish trend. Despite some mildly bullish daily moving averages, the broader technical indicators suggest caution for investors as the stock continues to underperform key benchmarks."
      },
      {
        "title": "Cohance Lifesciences Ltd Technical Momentum Shifts Amid Bearish Monthly Indicators",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/cohance-lifesciences-ltd-technical-momentum-shifts-amid-bearish-monthly-indicators-4219554",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/CohanceLifescie_technicaldot_4219554.png",
        "date": "2026-10-09 08:06:45",
        "description": "Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. This transition is underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting a complex market sentiment as the stock navigates a challenging environment."
      }
    ],
    "total": 88,
    "sid": "1003386",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/cohance-lifesciences-1003386"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "20-Nov-2026",
      "details": "Investor Meet",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "11-Nov-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Jasub Property Holdings LLP & Others",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "11-Nov-2026",
      "details": "Transcript of Con call",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Cohance Lifesciences Ltd has declared <strong>500%</strong> dividend, ex-date: 09 Sep 22",
          "dt": "2022-09-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Cohance Lifesciences Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 25 Sep 20",
          "dt": "2020-09-25",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

20-Nov-2026 | Source : BSE

Investor Meet

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

11-Nov-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Jasub Property Holdings LLP & Others

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

11-Nov-2026 | Source : BSE

Transcript of Con call

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Cohance Lifesciences Ltd has declared 500% dividend, ex-date: 09 Sep 22

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Cohance Lifesciences Ltd has announced 1:1 bonus issue, ex-date: 25 Sep 20

stock-summary
RIGHTS

No Rights history available